Search results Search for: Search Refine your results by duration: Any Under 5 mins Under 20 mins Over 20 mins Sort by: Relevance Views Date CBER's Perspective on Evaluation and Implementation of Rapid Microbial Methods CAPT Simleen Kaur, at FDA, Lori Daane at bioMérieux and Jon Kallay at Charles River Microbial Solutions Conventional microbiological methods are established and have been used for detection and identification of microbiological contamination in biologica... 3 months ago | 119 mins Points to consider when defining a microbial control strategy... Friedrich von Wintzingerode, PhD, QC Lead iNeST Project (individualized Neoantigen Specific Therapy) Full title: Points to consider when defining a microbial control strategy for individualized ATMPs How are individualized ATMPs different from tradit... 2 months ago | 55 mins Cannabis Cultivation: Water Management Johnny Burgoon, Mark Reich Adequate moisture and nutrients are crucial in ensuring your cannabis plant reaches its full potential. But it’s a difficult balance to strike. Too li... 3 weeks ago | 30 mins Considerations For Sterility Test Methods When Working With CDMOs Miriam Guest at AstraZeneca, Anne Weeks at Merck KGaA and Chris Berridge at Ecolab The confirmation of microbial quality of drug products manufactured by contract manufacturing organisations (CMOs) is a key component of product relea... September 14, 2023 2:00pm Active Attacks on Healthcare: Examples, Protections and Lessons Learned Asher Brass - Head of Cyber Network Analysis, Chad Holmes - Security Evangelist In recent years healthcare environments have become a prime target for cybercriminals due to underfunding, lack of expertise and lagging cybersecurity... 3 months ago | 58 mins CCAB: CCAB: Addressing the risk of microbial impurities... Dr Friedrich von Wintzingerode, QC Lead iNeST, Roche and Nahuel Paolini, PhD, Sanquin Reagents Full Title: CCAB: Addressing the risk of microbial impurities in Biologics and certain Advanced Therapy Medicinal Products (ATMPs) For parenteral dr... 1 year ago | 69 mins New Tools to Assess the Risk of Microbial Impurities in the Pharmaceutical... Presented by Friedrich von Wintzingerode Global QC at Roche Followed by Mathilde Arnault, Research Scientist at Merck KGaA, Full Title: New Tools to Assess the Risk of Microbial Impurities in the Pharmaceutical Manufacturing Process Large scale Production of Biologics is s... 4 years ago | 62 mins Rapid methods- The Next Phase : A Framework For Multi-Product Adoption... Miriam Guest, at AstraZeneca UK and Ulrich Herber at Charles River Full Title: Rapid methods- The Next Phase : A Framework For Multi-Product Adoption Of Rapid Sterility Testing The adoption of rapid sterility testing... 1 year ago | 120 mins Understanding the chemical mediators of ecological interactions Shinichi Sunagawa, Christelle A. M. Robert, and Emily R. Burdfield-Steel Chemical ecology integrates advances in chemistry and biology to better understand chemically-mediated biological interactions, how these interactions... 7 months ago | 103 mins A Comprehensive Approach to Assess the Impact of Microbial Impurities on Pat... Dr Friedrich von Wintzingerode, QC Lead iNeST Project at Roche and Shabnam Solati, CEO & Co-Founder at CTL-MAT FULL TITLE: A Comprehensive Approach to Assess the Impact of Microbial Impurities on Patient Safety and Product Quality of Biologics Presented by Dr ... 3 years ago | 80 mins Load more
